○Hikari Takanashi1, Hiroshi Kaneko1, Hidemasa Nakaminami1 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci.)
Session information
Poster Presentation
(C) Pharmaceutical Biology
[27P2-am1] Classification and evolution of microorganisms/Virus/Others
Mon. Mar 27, 2023 10:00 AM - 11:40 AM [Room P2] Gymnasium (1F)
○Ryo Kutsuna1, Toru Akiyama2, Yuki Muramatsu3, Moriyuki Hamada3, Junko Tomida1, Ken Kikuchi4, Yoshiaki Kawamura1 (1. Sch. Pharm., Aichi Gakuin Univ., 2. Res. Institute, NCGM, 3. NBRC, NITE, 4. Sch. Med., Tokyo Women's Medical Univ.)
○Ritsuko Kuwana1, Ryuji Yamazawa1, Kiyoshi Ito1, Hiromu Takamatsu1 (1. Pharm, Sci., Setsunan University)
Towa Kondoh1, Yuya Yamagoshi1, Daichi Morita1, Teruo Kuroda1, ○Takanori Kumagai1 (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ.)
○Nanami Hiramatsu1, Chiho Murakami1, Hiromi Shimizu1, Arowu R. Tanaka1, Yuichiro Sato1, Kinjiro Morimoto1 (1. Faculty of Pharm., Yasuda Woman’s Univ.)
○Ikuko Tsukamoto1,2, Shigehiro Kamitori1,2 (1. Fac. of Med., Kagawa Univ., 2. Int. Inst. of Rare Sugar Res. & Edu., Kagawa Univ.)
○Natsumi Ishikawa1, Satoshi Onodera2, Tsukasa Matsumoto1, Yuji Kikuchi1,2, Kazuyoshi Kawahara3, Satoshi Ishikawa1 (1. Fac. Pharm., Iryo Sosei Univ., 2. Grad. Sch. Life Sci. Technol., Iryo Sosei Univ., 3. Kanto Gakuin Univ.)
○Koyo Yoshihara1, Juri Koizumi1, Keisuke Nakase1, Hidemasa Nakaminami1 (1. Tokyo Univ. Pharm. Life Sci.)
○Toko Suzuki1, Yuji Miyazaki1, Juri Koizumi1, Keisuke Nakase1, Hidemasa Nakaminami1 (1. Tokyo Univ. Pharm. Life Sci.)
○Fumie Ito1, Daisuke Yamada1, Hinako Tomita1, Marika Hoshino1, Yutaka Tanaka1, Masato Sasaki1, Nobuyuki Shibata1 (1. Facul. Pharm. Sci., Tohoku Med. Pharm. Univ.)
○FUJIMATSU NORIHIKO1, Takuya Kuraoka1, Naoshi Tahara1, Honoka Tominaga1, Misaki Kouka1, Vishnu Chaturvedi2, Hidemitsu Kobayashi1 (1. Dept. Pharm. Sci., Nagasaki Int. Univ., 2. Dept. Health Sci., Wadsworth Center, New York)
○Nanako Yamauchi1, Nanaho Hiraga1, Takeshi Mori1,2, Takumi Umemura1, Kouichi Kato3, Masami Okudaira4, Tunemasa Nonogaki1, Hirosige Mikamo2, Yoshiaki Ikeda1 (1. Col. Pharm., Kinjo Gakuin Univ., 2. Dep. Infect. Con., Aichi Medical Univ. Hosp., 3. Fac. Pharm. Sci., Shonan Univ. Med. Sci., 4. Dep. Pharm., Anjo Kosei Hosp.)
○soga keisuke1, Jumpei Narushima1, Satoko Yoshiba1, Norihito Shibata1, Kazunari Kondo1 (1. National Institute of Health Sciences)
○Yuta Toritani1, Yuki Iwaisako1, Masahiro Fujimuro1 (1. Kyoto Pharmaceutical Univ.)
○Yurina Kitamura1, Marina Ikeda1, Yuki Iwaisako1, Yuichi Sekine1, Yuki Maemoto2, Akihiro Ito2, Masahiro Fujimuro1 (1. Kyoto Pharm. Univ., 2. Tokyo Pharm. Univ.)
○Kazushi Kuriyama1, Tadashi Watanabe1, Ohno Shinji1 (1. Grad. Sch. Med., Univ. of the Ryukyus)
○Haruka Sakaguchi1, Hirona Ichikawa1, Tetsuyuki Takahashi1, Takao Hijikata1 (1. Pharm. Sci., Musashino Univ.)
○Hirona Ichikawa1, Manami Seki1, Tetsuyuki Takahashi1, Takao Hijikata1 (1. Pharm. Sci. Musashino Univ.)
○Kyoko Saito1, Kentaro Shimasaki1, Masayoshi Fukasawa1, Ryosuke Suzuki2, Yuko Okemoto-Nakamura1, Kaoru Katoh3, Tomohiko Takasaki4, Kentaro Hanada5 (1. Dept. Biochem. Cell Biol., Natl. Inst. Infect. Dis., 2. Dept. Virol. II, Natl. Inst. Infect. Dis., 3. Biomed. Res. Inst, AIST, 4. Kanagawa Pref. Inst. Pub. Health, 5. Dept. Qual. Assur. Rad. Safe. Info. Sys., Natl. Inst. Infect. Dis.)
○Yoshiki Wakabayashi1, Yuuki Kurebayashi1, Mizuki Hayashiyashi1, Akira Minami1, Tadanobu Takahashi1, Takashi Suzuki1, Hideyuki Takeuchi1 (1. University of shizuoka)
○Masaki mineta1, Iori Matsuura1, Vyankatesh R. Kudkyal1, Hiroaki Hiramatsu1, Kyoko Hayashi1, Toshio Kawahara1, Yasuo Suzuki1, Shin-ichi Nakakita2, Yohei Watanabe3, Takao Ono4, Yasushi Kanai4, Kazuhiko Matsumoto4 (1. Chubu Univ., 2. Kagawa Univ., 3. KPUM, 4. SANKEN, Osaka Univ.)
○Ayano Okada1, Dai Hatakeyama1, Erina Nishikawa1, Tsugumi Honjoh1, Seiryo Ogata2, Takeshi Masuda2, Sumio Ohtsuki2, Takashi Kuzuhara1 (1. Fac. Pharmaceut. Sci., Tokushima Bunri Univ., 2. Grad. Sch. Pharmaceut. Sci., Kumamoto Univ.)
○Masahiro Kimura1, Shizuma Ishikawa1, Takashi Odagiri1, Naoto Yoshino1, Yasushi Muraki1 (1. Division of Infectious Diseases and Immunology, Department of Microbiology, School of Medicine, Iwate Medical University,)
○Miyu Furukawa1, Yuichiro Yamamoto1, Tetsuya Inoue1, Mana Murae1,2, Masayosi Fukasawa1,2, Kohji Noguch1,2 (1. Facult. Pharm. Sci. Tokyo Univ. Sci., 2. Natl. Inst. Infect. Dis)
○Mana Murae1,2, Shota Sakai2, Yoshimi Shimizu3, Nanami Yamamoto4, Kohji Noguchi1, Masayoshr Fukasawa2 (1. Grad. Sch. of Pharm. Sci., Tokyo Univ. Sci., 2. Dept. Biochem. Cell Biol. Natl. Inst. Infect. Dis., 3. Dept. of Pharm. Teikyo Heisei Univ., 4. Dept. of Sci., Tokyo Univ. Sci.)
○Keiko Ishino1,2, Yuko Udaka1,3, Mariko Iwase1,3, Hideto Oyamada1,3, Fumihiro Ishikawa1,4, Daisuke Tanaka5, Yuji Kiuchi1,3 (1. PCR Center for COVID-19, Showa University Hospital , 2. Grad. Sch. Pharm. Sci., Showa Univ., 3. Grad. Sch. Med. Sci., Showa Univ., 4. Centre for Biotechnology, Showa Univ, 5. Health Service Center, Showa Univ.)
○Kento Suzuki1, Daisuke Yamanaka1, Yoshiyuki Adachi1 (1. Tokyo Univ. Pharm. Life Sci)